Table 2 Comparison of the MTBDRplus assay with conventional drug susceptibility testing at onset and 5th month
| Â | Â | GENOTYPIC DST | |||
|---|---|---|---|---|---|
PHENOTYPIC DST | Â | INHs RIFs | INHr RIFs | INHs RIFr | INHr RIFr |
Onset (n = 88) | INHs RIFs | 43 | 7 | 0 | 0 |
| Â | INHr RIFs | 2 | 13 | 0 | 3 |
| Â | INHs RIFr | 0 | 0 | 1 | 1 |
| Â | INHr RIFr | 1 | 0 | 1 | 16 |
5th month (n = 67) | INHs RIFs | 1 | 0 | 0 | 0 |
| Â | INHr RIFs | 0 | 2 | 0 | 1 |
| Â | INHs RIFr | 0 | 0 | 1 | 2 |
| Â | INHr RIFr | 0 | 0 | 1 | 59 |